Pacira | Betriebsaufwand



Operating Expenses Veränderung Datum
Astellas Pharma JPY 633.6B 214.16B 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.63B 500M 2024-12
Ligand Pharmaceuticals USD 52.45M 3.78M 2024-12
Novo Nordisk 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12
Zoetis USD 1.59B 71M 2024-12



Pacira Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.